Abstract: Clostridium difficile causes pseudomembranous colitis and antibiotic-associated diarrhea. The definitive diagnosis of C. difficile infection is finally accomplished by the isolation of toxigenic C. difficile. However, only a small number of Japanese clinical laboratories are able to reach a definitive diagnosis of C. difficile infection, probably because simple reliable assays for toxins in the isolates are not available. In this study, we examined the compatibility of a polymerase chain reaction (PCR) assay and tissue culture assay to identify toxigenic C. difficile, in toxigenic and nontoxigenic C. difficile isolates from Japanese patients and healthy carriers. The specificity of PCR primers was demonstrated by restriction endonuclease digestion and seminested PCR in C. difficile VPI 10463 strain. No PCR product was amplified in the eight other clostridial species used to check the specifiecty of the PCR assay. The detection limit was 10 3 cells. Both toxin A and toxin B genes (the genes encoding the major virulence factors of C. difficile) were detected in 58 toxigenic C. difficile isolates, which showed a wide range of cytotoxic activity in tissue culture assays. Neither of the toxin genes was carried by 40 nontoxigenic strains of C. difficile. The results of this study strongly suggest that a definitive diagnosis of C. difficile infection can be accomplished by PCR detection of the toxin genes rather than by tissue culture assay of isolates.
Introduction
Clostridium difficile causes pseudomembranous colitis and antibiotic-associated diarrhea.
1,2 C. difficile is one of the most important causes of nosocomial infections. 2, 3 Toxins A and B, which are the major virulence factors of C. difficile, 1 are both cytotoxic, but toxin B has greater potency. Toxins A and B are encoded by two separate genes located in close proximity on chromosome. [4] [5] [6] The C-termini of both toxin genes contain similar repetitive sequences, which seem to function as binding domains to target cells. Both toxins are generally produced simultaneously.
The definitive diagnosis of C. difficile infection is accomplished by the isolation of toxigenic C. difficile from stool and detection of the toxins. 1 Tissue culture assays and immunological assays are used to detect toxins in stool and in the culture supernatants of the isolates. However, tissue culture assays require specialized equipment and trained personnel. Hence, commercial enzyme immunoassay kits are widely used. 2 At present in Japan, two commercial enzyme immunoassay kits, the VIDAS assay kit CDA2 (bioMérieux-Viteck Japan, Tokyo, Japan) and the CD check D-1 (Mitsubishi Chemical Industries, Tokyo, Japan), are the only available in-vitro diagnostics for C. difficile infection. The VIDAS assay kif CDA2 uses a monoclonal antibody to toxin A, but an automatic enzyme-linked fluorescence immunoassay system, (mini VIDAS; bioMérieux-Viteck Japan) is also required, therefore clinical laboratories which can employ this kit are limited. The disadvantage of the CD check D-1 kit is that it gives false-positive reactions to nontoxigenic C. difficile and to organisms other than C. difficile, as it detects glutamate dehydrogenase as an antigen. 7 Other commercial enzyme immunoassay kits commonly used in other countries for specific detection of the toxins are not available in Japan, as they are not approved by the Ministry of Health and Welfare of Japan. Therefore, only a small number of Japanese clinical laboratories (in which tissue culture assays, the VIDAS assay kit CDA2, or, althernatively, originally developed enzyme immunoassays, are employed for detection of C. difficile toxins) are able to reach a definitive diagnosis of C. difficile infection. This is probably one of the reasons for the relative lack of information and epidemiological data on C. difficile infection in Japan.
The polymerase chain reaction (PCR) is widely employed in research laboratories to diagnose microbial infections, by detecting the specific genes of causative agents. This method is now being used in Japanese clinical laboratories, and several commercial PCR kits are available as in-vitro diagnostics. The availability of rapid, simple assays such as PCR to detect C. difficile toxins should help the progress of Japanese clinical studies on C. difficile infection.
In the present study, to examine the compatibility of a PCR assay and tissue culture assay for the laboratory diagrosis of toxigenic C. difficile, we investigated the distribution of C. difficile toxin genes and cytotoxicity in toxigenic and nontoxigenic isolates from Japanese patients and healthy carriers.
Methods

Bacterial strains and cultivation
We used 98 strains of C. difficile isolated in this laboratory from healthy adults and patients with antibioticassociated diarrhea 8 , with C. difficile VPI 10463 as the reference. To check the specificity of the PCR assay, we used C. absonum KZ 482, C. bifermentus KZ 48, C. botulinum type A KZ 2, C. chauvoei KZ 378, C. histolyticum KZ 20, C. perfringens KZ 221, C. sordellii KZ 51, and C. tetani KZ 32. An 0.1-ml portion of liverbroth culture was inoculated into 10 ml of brain-heart infusion (Becton Dickinson Microbiology Systems, Cockeysville, MD, USA) supplemented with 0.2% Na 2 HPO 4 and incubated anaerobically at 37°C for 16 h. The culture was directly used for PCR. The filtrate of the 5-day-old culture was used for a tissue culture assay.
Quantitative determination of bacterial cells
The total number of C. difficile vegetative cells and spores was determined as described previously. 9 Briefly, an 0.1-ml aliquot of ten fold diluted bacterial culture was pipetted into 9-cm-diameter petri dishes and mixed with 20 ml of brain-heart infusion (Nissui Pharmaceutical, Tokyo, Japan) supplemented with 0.8% glucose, 1.0% soluble starch, 0.05% l-cysteine·HCl, 0.1% taurocholic acid sodium salt (Guaranteed reagent grade; Nacalai Tesque, Kyoto, Japan) and 1.3% agar. The inoculated agar plates were incubated anaerobically at 37°C for 3 days. The number of colonies was counted and was regarded as the number of both vegetative cells and spores.
Tissue culture assay
Cytotoxicity was examined by a microtitration assay, using baby hamster kidney cells, according to the method of Nakamura et al. 8 After twofold serial dilution of culture filtrates, 50 µl of each diluted sample was added to the cells. The reciprocal of the highest dilution resulting in 100% cell rounding after 24-h incubation was taken to be the number of cytotoxic units (CU) per 50-µl sample. Sizes of fragments to be amplified were: KAG1-KAG4, 905 bp; KAG8-KAG10, 1055 bp; KAG2-KAG4, 236 bp; KAG8-KAG9, 862 bp. PstIdigestion of the KAG1-KAG4 product generated 764-bp and 141-bp fragments, and HindIII-digestion of the KAG8-KAG10 product, 650-bp and 405-bp fragments. Amplification was accomplished in 50-µl aliquots containing 2 µl of bacterial culture, 50 pmol of each primer, 0.2 mM each dNTP, 1.5 mM MgCl 2, 50 mM KCl, 10 mM Tris-HCl, pH 8.3, 0.001%(w/v) gelatin, and 2.5 units of AmpliTaq DNA polymerase (Perkin Elmer, Foster City, CA, USA), with an Omn-E thermal cycler (Hybaid, Ashford, Middlesex, UK). Amplification conditions were 30 cycles at 94°C for 1 min, 55°C for 1.5 min, and 72°C for 1.5 min with KAG1-KAG4 and KAG8 KAG10, and 25 cycles at 94°C for 1 min, 55°C for 1 min, and 72°C for 1 min with KAG2-KAG4 and KAG8-KAG9. The PCR products were separated on agarose gel and visualized with ethidium bromide under ultraviolet (UV) light.
Results
PCR assay
Bacterial cultures were directly submitted to a PCR assay. When a 5-µl volume of the C. difficile VPI 10463 culture sample was used, false-negative PCR results were occasionally obtained, and therefore a sample volume of 2 µl was used. This volume contained around 10 5 cells (vegetative cells and spores). The specificity of the primers was ascertained with C. difficile VPI 10463. A single band of the expected size was amplified with KAG1-KAG4 (Fig. 1, lane 2) and KAG8-KAG10 (Fig.  1, lane 4) . PstI-digestion of the KAG1-KAG4 product and HindIII-digestion of the KAG8-KAG10 product generated the expected fragments (Fig. 1, lanes 3 and 5) , respectively. The specificity of the primers was further demonstrated by seminested PCR. When the KAG1-KAG4 product was used as the template, the expected fragment was amplified with KAG2-KAG4 (Fig. 1, lane  6) . A convincing result was also obtained by seminested PCR with KAG8-KAG9, using the KAG8-KAG10 product as the template (Fig. 1, lane 7) . When the eight clostridial species other than C. difficile were tested, no PCR product was amplified with KAG1-KAG4 or with KAG8-KAG10.
The sensitivity of the PCR with KAG1-KAG4 and KAG8-KAG10 was examined with C. difficile VPI 10463. A 2-µl volume of each ten fold dilution of bacterial culture was directly added to the reaction mixture. After 30 cycles of amplification, 10 3 cells (vegetative cells and spores) were detected with both primer sets of KAG1-KAG4 and KAG8-KAG10 (Fig. 2) .
Tissue culture assay
The 98 C. difficile strains isolated in our Japanese population were examined by tissue culture assay. Fiftyeight strains showed cytotoxic activity (ranging from 2 4 to 2 14 CU per 50-µl sample) while the remaining 40 strains showed no cytotoxic activity.
Presence of C. difficile toxin genes
The presence or absence of C. difficile toxin genes was examined by PCR assay with the primer sets of KAG1-KAG4 and KAG8-KAG10. The toxigenic strains carried both the toxin A and B genes (Table 1) . (None of the toxigenic strains carried only one of these genes). No size variation was observed in the two toxin gene 
a ϩ, cytotoxicity-positive; Ϫ, cytotoxicity-negative b ϩ, gene-positive; Ϫ, gene-negative 1 2 3 4 5 6 7 bp 1000 500 100 Fig. 1 . Agarose gel electrophoresis of polymerase chain reaction (PCR) products amplified with primers specific for the toxin A and B genes, and their restricted fragments. C. difficile VPI 10463 was used for PCR. Lane 1, Molecular size marker (AmpliSize; Bio-Rad Laboratories, Hercules, CA, USA); lane 2, the KAG1-KAG4 product (the toxin A gene fragment); lane 3, the PstI-digested KAG1-KAG4 product together with the non-digested product; lane 4, the KAG8-KAG10 product (the toxin B gene fragment); lane 5, the HindIII-digested KAG8-KAG10 product together with the non-digested product; lane 6, seminested PCR product with KAG2-KAG4, using the KAG1-KAG4 product as template; lane 7, seminested PCR product with KAG8-KAG9, using the KAG8-KAG10 product as template fragments. The nontoxigenic strains, without exception, did not carry either of the toxin genes.
Discussion
In this study, we found that in C. difficile isolates from Japanese subjects, nontoxigenic strains lacked the genes for both toxins A and B, while all toxigenic strains carried both the toxin genes. Complete agreement between the presence of both toxin genes and cytotoxicity has also been found in C. difficile isolates from The Netherlands 12 and from Denmark. 13 These findings indicate that both the toxin A and B genes (or either one) are stably expressed in the C. difficile organism, suggesting that a definitive diagnosis of C. difficile infection can be accomplished by PCR detection of the toxin genes, rather than by tissue culture assay or enzyme immunoassay of isolates from stool.
The strains tested showed wide range of cytotoxic activity. This may be explained by transcription levels of the toxin genes. [14] [15] [16] Hammond et al. 14 analyzed several strains and showed that quantitative differences in toxin-specific transcripts (mRNA) were correlated with the titer of toxin protein, and that this transcriptional regulation was not caused by DNA sequence differences in the regulatory region (ORFtxe1). They suggested that a trans-acting factor may be involved in the transcriptional regulation. The regulation of C. difficile toxin production should be further elucidated.
Several PCR assays for detecting toxigenic C. difficile have been described. 12, 13, [17] [18] [19] However, most of these studies involved DNA extraction steps that included boiling of cultures, which is laborious when a large number of strains are to be handled. In addition, polymorphisms in the toxin A and B genes have been reported. [20] [21] [22] Characteristic differences between strains mainly occur in the 5Ј third of the toxin B gene and the 3Ј third of the toxin A gene. 22 Therefore, PCR primers located in these regions are not suitable for detecting the toxin genes, except for specific purposes such as molecular epidemiology. Our PCR method was developed to overcome these problems.
The Japanese carrier rate of toxigenic C. difficile is estimated to be around 10%. 8 This rate seems to be higher than the carrier rate of 3% reported by George. 23 The present study indicates that the PCR assay, because of its simplicity and reliability, would also be useful for such epidemiological studies of C. difficile infection.
We hope that this study will prompt Japanese studies of C. difficile and its infection.
